Label: BRILLIA HEALTH COLD-FLU RECOVERY (lapine histamine immune globulin (12c, 30c, 50c), lapine interferon gamma immune globulin (12c, 30c, 50c), lapine cd4 immune globulin- 12c, 30c, 50c tablet

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved homeopathic

DISCLAIMER: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

Drug Label Information

Updated January 18, 2022

If you are a consumer or patient please visit this version.

View All Sections
  • Active Ingredients

    Lapine interferon gamma immune globulin 12C, 30C, 50C Purpose: enchance magnitude of immune response

    Lapine histamine immune globulin 12C, 30C, 50C Purpose: reduce histamine and inflammation response

    Lapine CD4 immune globulin 12C, 30C, 50C Purpose: Enhance functional activity of immune system

  • Purpose

    Homeopathic,

    Enhance magnitude of immune response

    Reduce histamine and inflammation response

    Enhance functional activity of immune system

  • Uses

    • Shorten the duration of flu and cold symptoms
    • Reduce severity of flu and cold symptoms, including nasal congestion, cough and sore/itchy throat

  • Warnings

    Ask a doctor or pharmacist before use if you are lactose-intolerant.


    Stop use and ask a doctor if symptoms persist or worsen.


    If pregnant or breast-feeding, ask a health professional before use.


    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.


    A llergic (hypersensitivity) reactions may occur in very rare cases.


    Do not use if known sensitivity to Brillia Health Cold-Flu Recovery or any of its ingredients exists.

  • Ask a doctor

    Ask a doctor or pharmacist before use if you are lactose-intolerant.


  • STOP USE

    Stop use and ask a doctor if symptoms persist or worsen.


  • PREGNANCY OR BREAST FEEDING

    If pregnant or breast-feeding, ask a health professional before use.


  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.


  • Allergic Reaction

    Allergic (hypersensitivity) reactions may occur in very rare cases.


  • DO NOT USE

    Do not use if known sensitivity to Brillia Health Cold-Flu Recovery or any of its ingredients exists.

  • Directions


    • For adults and children 1 year and older.
    • Hold tablet in mouth until completely dissolved, without food. If necessary, tablet can be taken dissolved in 1 tablespoon of drinking water.
    • Day 1: 8 tablets total for the first day
    1 tablet every 30 minutes for the first 2 hours
    (a total of 5 tablets over 2 hours),
    1 tablet taken 3 more times at equal intervals
    (a total of 3 tablets over the remainder of the day).
    • Days 2 to 5: 1 tablet 3 times a day
    (at equal intervals).

  • Other Information

    • Store in original package below 25°C or 77°F.
    • Do not use if blister pack is torn or broken.

  • Inactive Ingredients

    Lactose monohydrate, Magnesium stearate, Microcrystalline cellulose.

  • PRINCIPAL DISPLAY PANEL

    40 Tablets NDC: 72123-006-01

    LABEL 1

  • INGREDIENTS AND APPEARANCE
    BRILLIA HEALTH COLD-FLU RECOVERY 
    lapine histamine immune globulin (12c, 30c, 50c), lapine interferon gamma immune globulin (12c, 30c, 50c), lapine cd4 immune globulin (12c, 30c, 50c) tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72123-006
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LAPINE INTERFERON GAMMA IMMUNE GLOBULIN (UNII: Q2KS2OI6SA) (LAPINE INTERFERON GAMMA IMMUNE GLOBULIN - UNII:Q2KS2OI6SA) LAPINE INTERFERON GAMMA IMMUNE GLOBULIN12 [hp_C]
    LAPINE HISTAMINE IMMUNE GLOBULIN (UNII: 7U4T47R0DD) (LAPINE HISTAMINE IMMUNE GLOBULIN - UNII:7U4T47R0DD) LAPINE HISTAMINE IMMUNE GLOBULIN12 [hp_C]
    LAPINE CD4 IMMUNE GLOBULIN (UNII: UIF41K6WR9) (LAPINE CD4 IMMUNE GLOBULIN - UNII:UIF41K6WR9) LAPINE CD4 IMMUNE GLOBULIN12 [hp_C]
    Inactive Ingredients
    Ingredient NameStrength
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    Product Characteristics
    ColorwhiteScorescore with uneven pieces
    ShapeROUND (round tablets) Size9mm
    FlavorImprint Code other
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72123-006-012 in 1 BOX07/31/2020
    120 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved homeopathic07/31/2020
    Labeler - Hadaf LLC (094114708)
    Establishment
    NameAddressID/FEIBusiness Operations
    Santonika Uab520214047manufacture(72123-006)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!